World City Press – Lifestyle
Author:
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer’s Disease
May 13, 2026
Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution
April 28, 2026
Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework
April 28, 2026
Fosun Pharma Announces 2025 Annual Results
March 24, 2026